Skip to content
Subscriber Only

Opioid Makers Face Heat From Investors With $1.3 Trillion

  • Unions, pension funds blame companies for epidemic of abuse
  • Coalition says it will seek accountability measures for boards
Video player cover image

How America's Opioid Crisis Spiraled Out of Control

Updated on

Drug companies that profit from opioids need to do more to limit the risks of the addictive products and protect shareholders against losses, according to a group of investors managing more than $1.3 trillion.

Investors for Opioid Accountability plans to file shareholder proposals on board oversight of business risks at 10 manufacturers and distributors, the coalition of unions, public pension funds and state treasurers said Monday in an emailed statement.